Skip to content

Public FDA record

Z-2943-2020: Talladium Luminesse Zirconia Discs, Zirconia HT Disc 98x20mm A1, Shaded Zirconia Blend 2.0 50# A1, Model

Recall record Z-2943-2020 for Talladium Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2943-2020
Company in FDA record
Talladium Inc
FDA record creation date
Sep 9, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The linear shrinkage on the zirconia blank disc s part label is incorrect. The average linear shrinkage found on the product label was outside the acceptable range. The acceptable average linear shrinkage ranges between 1.225 to 1.275. The production lot being recalled has a linear shrinkage rate of 2.251 which is above the acceptable range.

Source facts

Action
The recall notification letters were sent on 08/12/2020, via FedEx Priority Overnight. The following is included in the recall notification as actions required: Immediately check your stock and quarantine the affected stock on hand to prevent further use. Using the provided customer letter and Recall Acknowledgement Form templates, communicate this recall to any of your customers who have received product included within the scope of the recall. To return product, complete the Recall Acknowledgement Form, scan and email to productrecall@talladium.com, Attn: Michael Capellan. This will allow to document the amount of product you have on hand for return. A customer service representative will contact you with a Return Merchandise Authorization (RMA) Number and will provide instructions for the return of product. Using the provided customer letter and Recall Acknowledgement Form templates, communicate this recall to any of your customers who have received product included within the scope of the recall. Have the customers return any affected product to you, together with a completed Recall Acknowledgement Form, for consolidation and return to the recalling firm. Please complete the attached Acknowledgement form even if you do not have any affected stock, scan and email to productrecall@talladium.com or mail to 27360 W. Muirfield Lane, Valencia, CA 91355. ATTN: Michael Capellan PRODUCT RECALL. You can also report an adverse event to the FDAs MedWatch Adverse Event Reporting program: A. Online at: http://www.fda.gov/safety/medwatch/howtoreport/default.htm B. Report by telephone: 1-800-FDA-1088 or Fax report: 1-800-FDA-0178. If you have any other questions, feel free to contact Michael Capellan at michael@talladium.com.
Initiated
2020-08-06
Root cause
Under Investigation by firm
Terminated
2022-10-07
Distribution
U.S. Nationwide distribution including in the states of CA, FL, KS, LA, MO, and PA. No OUS Consignees.
Recall number
Z-2943-2020
Recall status
Terminated
CDRH record ID
183130
FDA record created
2020-09-09
Recall event number
86227

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗